Owner Morria Biopharmaceuticals Inc.

Inventors Yedgar, Saul

Agent Davies Collison Cave

Pub. Number AU-B-2005218545

PCT Pub. Number WO2005/084307

Priority 10/790,182 02.03.04 US

Filing date 2 March 2005

Wipo publication date 15 September 2005

Acceptance publication date 16 December 2010

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/717 (2006.01)

A61K 31/727 (2006.01)

A61K 31/728 (2006.01)

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07F 9/10 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07F 9/117 (2006.01) Compounds containing elements of the 5th Group of the Periodic System

C07H 5/04 (2006.01) Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 5/06 (2006.01) Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium

C07H 15/06 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

C07H 15/10 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals